FSA Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Buy
+351
New +$359K 0.19% 147
2025
Q4
Sell
-469
Closed -$358K 232
2025
Q3
$358K Sell
469
-37
-7% -$27.5K 0.28% 99
2025
Q2
$394K Sell
506
-41
-7% -$31.9K 0.32% 94
2025
Q1
$452K Buy
547
+62
+13% +$51.6K 0.36% 88
2024
Q4
$374K Sell
485
-339
-41% -$281K 0.46% 78
2024
Q3
$736K Sell
824
-271
-25% -$244K 0.73% 39
2024
Q2
$918K Buy
1,095
+445
+68% +$356K 0.96% 30
2024
Q1
$506K Buy
+650
New +$463K 0.54% 60

Other funds holding LLY

FSA Advisors's LLY Position: Q2 2026 in Review

FSA Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 351 shares worth $421K. The stake represents 0.19% of the portfolio and ranks #147 among its holdings. This is a return to the name: FSA Advisors previously reported a position in LLY as recently as Q3 2025.

FSA Advisors first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. The position peaked at $918K in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FSA Advisors held 351 shares of Eli Lilly worth $421K as of Q2 2026.
  • Eli Lilly was a new FSA Advisors position in Q2 2026.
  • Eli Lilly made up 0.19% of FSA Advisors's portfolio in Q2 2026, its #147 holding.
  • FSA Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • FSA Advisors's Eli Lilly position peaked at $918K in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FSA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.